Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netarsudil aqueous humor dynamics in healthy volunteers
NCT02406287Phase 1Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Apr 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Glaucoma and ocular hypertension comparing Netarsudil with Placebo (2 arms). Primary endpoints: Change in aqueous humor flow rate at Day 8, Change in outflow facility at Day 8 and 3 more. Started Apr 2015; status: completed.
02
Drugs
netarsudil
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT02406287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406287.